Skip to content
Recruiting

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

About this study

This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.

Condition
Early Gastric Cancer, Advanced Gastric Cancer, Early Lung Cancer, Advanced Lung Cancer, Early Breast Cancer, Advanced Breast Cancer, Early Colon Cancer, Advanced Colon Cancer
Tested
Standardized Telenursing, Smart Cancer Care Plus
Sponsor
Ulsan University Hospital

Who can join

Age
19 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 7

  • Minimum age: 19 years
  • Study condition: Early Gastric Cancer, Advanced Gastric Cancer, Early Lung Cancer, Advanced Lung Cancer, Early Breast Cancer, Advanced Breast Cancer, Early Colon Cancer, Advanced Colon Cancer
  • Adults aged 19 years or older
  • Diagnosed with early or advanced gastric, lung, breast, or colon cancer
  • Starting first-cycle chemotherapy with a new anticancer agent
  • Able to use a smartphone without difficulty
  • Willing to provide informed consent to participate in the study

Exclusion 3

  • Individuals who have difficulty communicating due to cognitive impairment, visual impairment, hearing impairment, or other reasons
  • Individuals who cannot read, write, or understand Korean
  • Other individuals deemed inappropriate for participation by the investigators

Where

5 sites, 5 recruiting

Kosin University Gospel Hospital

Busan, South Korea

Recruiting

National Cancer Center, Korea

Goyang, South Korea

Recruiting

Gyeongsang National University

Jinju, South Korea

Recruiting

Ulsan University Hospital

Ulsan, South Korea

Recruiting

Gachon University Gil Medical Center

Incheon, South Korea

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.